Managing Metabolic Disorders Pharmacy CE Conference (4 hrs.)

Managing Metabolic Disorders Pharmacy CE Conference (4 hrs.)

Managing Metabolic Disorders Pharmacy CE Conference (4 hrs.)

August 24, 2024 - August 25, 2024

Managing Metabolic Disorders Pharmacy CE Conference

 

Saturday, August 24, 202

Mitigation and Prevention of Medication Errors in Pharmacy Practice

2:30-4:30pm General

Norman P. Tomaka, BS Pharm, MS, CPh, FAPhA, Clinical Consultant Pharmacist, Consultant Pharmacy Services

Upon completion of this activity, pharmacists will be able to:  Recognize statutory responsibilities that foster ongoing pharmacy regulatory compliance; Recognize recurring medication errors; Describe quality improvement regulations for pharmacies licensed in Florida; Define elements of a proactive Continuous Quality Improvement process that promotes ongoing quality; Discuss the use of Root Cause Analysis(RCA) to enhance quality pharmacy services and prevent errors; Describe the implementation of an action plan to improve overall pharmacy practice quality and mitigate medication errors; Demonstrate enactment of procedures that promote ongoing patient safety in pharmacy practice.

UAN: 0675-0000-24-025-L05-P

Sunday, August 25, 2024

Validation and Counseling of Prescriptions for Controlled Substance & Opioids

2:30-4:30pm General

Joseph Cammilleri, PharmD, BCACP, CPE, Ambulatory Care Clinical Pharmacist, Pain Management, PGY2 Pain/Palliative Care Program Director, UF Health.

Upon completion of this activity, pharmacists will be able to: Describe how to ensure access to controlled substances for all patients with a valid prescription; Use the Prescription Drug Monitoring Program’s Database; Assess prescriptions for appropriate therapeutic value; Detect prescriptions that are not based on a legitimate medical purpose; Discuss the laws and rules related to the prescribing and dispensing of controlled substances; Discuss proper patient storage and disposal of controlled substances; Discuss protocols for addressing and resolving problems recognized during the drug utilization review; Provide education on section 381.887, F.S., emergency treatment for suspected opioid overdoses and on the State Surgeon General’s Statewide Standing Order for Naloxone; Counsel patients with opioid prescriptions; Provide available treatment resources for opioid physical dependence, addiction, misuse, or abuse.

UAN: 0675-0000-24-030-L08-P*

 

No Comments

Comments are closed.